Home » Topics » Regulatory

Regulatory
RSS

Approval for prefilled syringe presentation of Ovidrel

Oct. 14, 2003

Inspra approved for congestive heart failure in heart attack patients

Oct. 13, 2003

Abbott seeks approval for Humira for improvement of physical function in RA

Oct. 6, 2003

FDA approves Zomig nasal spray

Oct. 6, 2003

Positive phase III results for Actiza

Oct. 2, 2003

Approvable letter issued for Lexapro in GAD

Oct. 1, 2003

Integrin antagonists useful for angiogenesis-related ocular diseases

Sep. 30, 2003

Thyrogen indication extended in Europe

Sep. 30, 2003

FDA advisory committee recommends expanded label for Provigil

Sep. 30, 2003

Lumiracoxib approved by the MHRA for osteoarthritis and other indications

Sep. 25, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...